PAX5 and B-cell chronic lymphocytic leukemia: Interestingly, BET inhibitors such as JQ1 were proposed as an effective strategy to target CLL cell growth, since they downregulated the expression of essential TFs (PAX5, MYC, IKZF1 and RARA) [86].